Guilong Bone-Setting Pill and its Preparation Process
By employing graded pulverization and microwave drying processes, the problems of volatile component loss and resinous herbal material adhesion in traditional Chinese medicine compound preparations have been solved, enabling the efficient preparation of Guilong Jiegu Pills and ensuring the quality and efficiency of the drug.
Patent Information
- Application Number
- CN202611392924.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-09
- Publication Date
- 2026-11-17
AI Technical Summary
In existing technologies, volatile components of traditional Chinese medicine compound preparations are easily lost during the preparation process, resin-based medicinal materials have prominent adhesion problems during pulverization, and traditional drying methods are inefficient and result in significant component loss.
The process employs a graded pulverization technique. First, medicinal materials containing volatile oil components are pulverized separately at a temperature controlled below 60°C. Then, they are mixed and pulverized with resinous medicinal materials, using starch paste as a binder, and dried using microwave at a temperature below 60°C.
It effectively avoids heat loss of volatile components, improves pulverization efficiency and product yield, shortens drying time, and ensures the safety and efficacy of the drug.
Smart Images

Figure CN123101616A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of traditional Chinese medicine preparation technology, and in particular to a Guilong Jiegu Pill and its preparation process. Background Technology
[0002] Fractures, dislocations, and soft tissue injuries are common and frequently occurring diseases in orthopedics. Clinical manifestations include swelling and stinging pain at the affected area, fixed pain that does not move, aggravation after activity, numbness and contracture, and difficulty in joint flexion and extension. Traditional Chinese medicine has a long history and unique advantages in the treatment of bone injuries. Compound Chinese medicine preparations with the principles of promoting blood circulation, removing blood stasis, and reconnecting tendons and bones have shown significant efficacy in clinical applications.
[0003] Guilong Bone-Setting Pills are composed of 23 Chinese herbs, including safflower, drynaria fortunei, vinegar-processed frankincense, vinegar-processed myrrh, chuanxiong rhizome, ground beetle, calcined natural copper, angelica root, charred eucommia bark, achyranthes root, earthworm, notoginseng, dragon's blood, borneol, borax, artemisia capillaris, catechu, fanghai (a type of herb), papaya, cinnamon twig, atractylodes rhizome, rhubarb, and licorice root. They have the effects of promoting blood circulation, removing blood stasis, relieving pain, and healing injuries by reconnecting tendons and bones. They have been used clinically for many years with definite efficacy.
[0004] In the existing technology, the preparation of traditional Chinese medicine compound preparations containing volatile components and resinous medicinal materials usually faces the following technical challenges: (1) Volatile components are easily lost. The prescription contains herbs such as Ligusticum chuanxiong, Angelica sinensis, and Atractylodes lancea, which contain volatile oils. In traditional preparation processes, the mechanical friction during the pulverization of herbs generates a large amount of heat, leading to an increase in the temperature of the pulverization chamber and easily causing the loss of volatile active ingredients. In addition, if the drying process is too hot or the drying time is too long, it will also lead to the loss of volatile components. How to retain the volatile active ingredients to the maximum extent while ensuring the quality of the formulation is the key technical challenge in the preparation of compound preparations containing such herbs.
[0005] (2) Adhesion problem of resinous medicinal materials during pulverization. The prescription contains resinous medicinal materials such as vinegar-processed frankincense, vinegar-processed myrrh, dragon's blood, and borneol. These medicinal materials are easily softened and adhered to the inner wall of the pulverizer due to heat generated by mechanical friction during individual pulverization. This not only affects the pulverization efficiency but also causes material loss and cleaning difficulties.
[0006] (3) Traditional drying methods are inefficient and result in significant component loss. Water pellets need to be dried after preparation. Traditional oven drying takes a long time (under experimental conditions, it takes 265 minutes to dry 100g of water pellets in an oven at 60℃). Prolonged heating not only consumes a lot of energy but also exacerbates the loss of volatile components. Although fluidized bed drying is more efficient, the equipment is complex and the operation requirements are high. Summary of the Invention
[0007] In view of the problems of easy loss of volatile components and adhesion of resin-based medicinal materials when pulverized in the existing technology, as well as the low efficiency and large component loss of traditional drying methods, the present invention is proposed.
[0008] Therefore, the purpose of this invention is to provide a Guilong Jiegu Pill, which aims to: design a graded pulverizing process based on the physical properties of different medicinal materials in the prescription. First, the three medicinal materials containing volatile oil components, namely Chuanxiong, Danggui, and Cangzhu, are mixed and pulverized separately. The pulverization is completed when the initial temperature of the pulverizer is low. The average temperature rise of the powder is only 15°C, and it will not exceed 60°C even in the high temperature environment of summer, effectively avoiding the heat loss of volatile components.
[0009] To solve the above-mentioned technical problems, the present invention provides the following technical solution: a Guilong Bone-Setting Pill, made from the following Chinese medicinal materials in parts by weight: safflower 65-85 parts, drynaria fortunei 65-85 parts, vinegar-processed frankincense 65-85 parts, vinegar-processed myrrh 65-85 parts, chuanxiong rhizome 45-65 parts, ground beetle 45-65 parts, calcined natural copper 35-55 parts, angelica sinensis 25-45 parts, charred eucommia bark 25-45 parts, achyranthes bidentata 2... 5-45 parts, earthworm 25-45 parts, Panax notoginseng 25-45 parts, dragon's blood 10-25 parts, borneol 10-25 parts, borax 25-45 parts, Artemisia annua 25-45 parts, catechu 25-45 parts, oyster shell 25-45 parts, papaya 25-45 parts, cinnamon twig 25-45 parts, Atractylodes lancea 45-65 parts, rhubarb 15-30 parts, licorice 25-45 parts, and pharmaceutically acceptable excipients.
[0010] In a preferred embodiment of the Guilong Jiegu Pill of the present invention, the pharmaceutically acceptable excipient is starch paste.
[0011] As a preferred embodiment of the Guilong Bone-Setting Pill of the present invention, the Guilong Bone-Setting Pill has a specification of 0.6 grams per 10 pills.
[0012] To achieve the above objectives, the present invention provides the following technical solution: a preparation process for Guilong Jiegu Pills, comprising the following steps: Step 1, Graded Grinding: Take three medicinal materials, Chuanxiong, Danggui, and Cangzhu, mix and grind them to obtain the first mixed powder; take the remaining sixteen medicinal materials, excluding vinegar-processed frankincense, vinegar-processed myrrh, blood dragon, and borneol, mix and grind them to obtain the second mixed powder; combine the first mixed powder, the second mixed powder, and vinegar-processed frankincense, vinegar-processed myrrh, blood dragon, and borneol, mix and grind them, and pass them through a 100-mesh sieve to obtain fine powder of medicinal materials; Step 2, preparation of starch paste: Take starch and add water to make a 10% starch paste; Step 3: Mixing to form a soft material: Place the fine powder of medicinal materials obtained in Step 1 into a mixer and mix evenly. Add the starch paste obtained in Step 2 to form a soft material. Step 4: Pelletizing: Place the soft material obtained in Step 3 into a pelletizing machine to make pellets; Step 5: Drying: The pills obtained in Step 4 are dried in a microwave at a temperature below 60°C to obtain Guilong Jiegu Pills.
[0013] As a preferred embodiment of the preparation process of Guilong Jiegu Pill of the present invention, in step one, the temperature of the materials is controlled not to exceed 60°C during the mixing and pulverizing of the three medicinal materials, namely, Chuanxiong, Danggui, and Cangzhu.
[0014] As a preferred embodiment of the preparation process of Guilong Jiegu Pill of the present invention, in step one, the vinegar-processed frankincense, vinegar-processed myrrh, blood dragon, and borneol are subjected to appropriate crushing treatment before being combined and pulverized.
[0015] In a preferred embodiment of the preparation process of Guilong Jiegu Pills according to the present invention, in step five, the microwave drying is carried out at a temperature below 60°C for 30-40 minutes.
[0016] As a preferred embodiment of the preparation process of Guilong Jiegu Pills of the present invention, in step one, after passing through a 100-mesh sieve, the pulverization and sieving yield is not less than 93%.
[0017] As a preferred embodiment of the preparation process of Guilong Jiegu Pills according to the present invention, at least one of the following thin-layer chromatography identification methods is used for quality identification: (1) Thin-layer chromatographic identification of safflower: Using safflower reference material as a reference, ethyl acetate-formic acid-water-methanol (7:2:3:0.4) was used as the developing solvent and examined under sunlight; (2) Thin-layer chromatographic identification of frankincense and myrrh: frankincense and myrrh reference materials were used as references, and petroleum ether (30-60℃)-ethyl acetate (17:1) was used as the developing solvent. 5% vanillin sulfuric acid solution was sprayed and heated until the spots were clearly visible. (3) Thin-layer chromatographic identification of Angelica sinensis and Ligusticum chuanxiong: Angelica sinensis and Ligusticum chuanxiong reference materials were used as references, and hexane-ethyl acetate (9:1) was used as the developing solvent. The samples were examined under ultraviolet light (365nm). (4) Thin-layer chromatography identification of Panax notoginseng: Panax notoginseng saponin R1 was used as the reference standard, and the lower layer solution of chloroform-ethyl acetate-methanol-water (15:40:22:10) placed below 10°C was used as the developing solvent. 10% sulfuric acid ethanol solution was sprayed on and heated until the spots were clearly visible. (5) Thin-layer chromatography identification of catechu: using catechu reference material and catechin reference standard as references, using toluene-ethyl acetate-formic acid (30:25:4) as the developing solvent, spraying with 2% ferric chloride ethanol solution, and heating until the spots are clearly visible; (6) Thin-layer chromatographic identification of rhubarb: using rhein as reference standard, n-hexane-ethyl acetate-formic acid (6:2:0.1) as developing solvent, examine under ultraviolet light (365nm), and the spots turn red after being exposed to ammonia vapor; (7) Thin-layer chromatographic identification of licorice: Using licorice reference material and glycyrrhizin reference standard as references, using ethyl acetate-formic acid-glacial acetic acid-water (15:1:1:2) as the developing solvent, spraying with 10% sulfuric acid ethanol solution, heating, and examining under ultraviolet light (365nm).
[0018] As a preferred embodiment of the preparation process of Guilong Jiegu Pills according to the present invention, the Guilong Jiegu Pills are used in the preparation of drugs for treating fractures, dislocations or soft tissue injuries.
[0019] Compared with the prior art, the present invention has at least the following beneficial effects: 1. This invention utilizes the physical properties of different medicinal materials in the prescription to design a graded pulverization process. First, three medicinal materials containing volatile oil components—Ligusticum chuanxiong, Angelica sinensis, and Atractylodes lancea—are individually mixed and pulverized. Pulverization is completed when the initial temperature of the pulverizer is low, with an average temperature rise of only 15°C, which will not exceed 60°C even in high-temperature summer environments, effectively avoiding heat loss of volatile components. Subsequently, fifteen medicinal materials without resinous components are mixed and pulverized. Finally, resinous medicinal materials such as vinegar-processed frankincense, vinegar-processed myrrh, dragon's blood, and borneol are mixed with the pulverized medicinal materials and pulverized together. Utilizing the isolation and dispersion effects of other medicinal powders, the softening and adhesion phenomenon of resinous medicinal materials during the pulverization process is effectively reduced, improving pulverization efficiency and yield. The pulverization and sieving yield in three batches of trials all reached over 93%.
[0020] 2. This invention adopts a process route of directly making pills from raw drug powder and starch paste, which is different from the traditional method of making pills after water decoction extraction. This avoids the loss of volatile components during the extraction and concentration process. In the drying stage, 10% starch paste is selected as the binder and microwave drying at a temperature below 60°C is used. The drying time is only about 33 minutes, which is nearly 90% shorter than oven drying (265 minutes). Microwave drying can kill microorganisms while quickly removing moisture, and the sterilization effect of microwaves can kill microorganisms, so as to achieve simultaneous drying and sterilization. Moreover, due to the short drying time and controllable temperature, volatile components can be well preserved, which fully ensures the safety and efficacy of the drug. Attached Figure Description
[0021] Figure 1 This is a flowchart of the preparation process of Guilong Jiegu Pill of the present invention. Detailed Implementation
[0022] To make the above-mentioned objects, features and advantages of the present invention more apparent and understandable, the specific embodiments of the present invention will be described in detail below with reference to the accompanying drawings.
[0023] I. Sources and Pre-processing of Chinese Herbal Raw Materials The twenty-three medicinal materials used in the embodiments of this invention all conform to the 2015 edition of the Pharmacopoeia of the People's Republic of China or relevant local standards, and were used after passing inspection.
[0024] The sources, identification, and testing of Chinese medicinal materials are shown in the table below:
[0025]
[0026]
[0027] II. Prescription Safflower 73.5g, Drynaria fortunei 73.5g, Vinegar-processed Frankincense 73.5g, Vinegar-processed Myrrh 73.5g, Ligusticum chuanxiong 54.4g, Eupolyphaga sinensis 54.4g, Calcined Natural Copper 44.0g, Angelica sinensis 36.8g, Eucommia ulmoides charcoal 36.8g, Achyranthes bidentata 36.8g, Pheretima aspergillum 36.8g, Panax notoginseng 36.8g, Dragon's Blood 17.6g, Borneol 17.6g, Borax 36.8g, Artemisia capillaris 36.8g, Catechu 36.8g, Evodia rutaecarpa 36.8g, Chaenomeles speciosa 36.8g, Cinnamomum cassia 36.8g, Atractylodes lancea 54.4g, Rheum palmatum 22.0g, Licorice 36.8g. Add appropriate amount of starch to make 1000g.
[0028] III. Preparation Process Research Example 1: Study on Grinding Process This product contains Chinese medicinal herbs such as Chuanxiong, Danggui, and Cangzhu, which contain volatile components. During the pulverization and drying process, excessively high temperatures should be avoided to prevent the loss of active ingredients. Additionally, the formula contains resinous herbs such as vinegar-processed frankincense, vinegar-processed myrrh, dragon's blood, and borneol, which are prone to softening and adhering to the pulverizer during the pulverization process, requiring a special pulverization strategy.
[0029] (1) Pulverization of medicinal materials containing volatile components Take 54.4g of Ligusticum chuanxiong, 36.8g of Angelica sinensis, and 54.4g of Atractylodes lancea (total 145.6g), and mix and pulverize them (without using a sieve during pulverization). Pulverization should be completed when the pulverizer is at its initial low temperature to minimize heat loss of volatile components. The results of three batches of experiments are as follows:
[0030] The results showed that the average temperature rise of the medicinal powder during the pulverization process was 15℃, and even under extreme conditions of 35℃ in summer, the temperature of the medicinal material would not exceed 60℃. During operation, the temperature rise of the pulverizer should be monitored, and if the temperature exceeds the limit, intermittent pulverization should be used to complete the pulverization operation.
[0031] (2) Mixing and pulverizing the remaining medicinal materials After pulverizing the medicinal materials containing volatile oils, there is no need to clean the pulverizer. Continue to mix and pulverize the remaining fifteen medicinal materials, excluding vinegar-processed frankincense, vinegar-processed myrrh, dragon's blood, catechu, and borneol. Combine the two batches of powder for later use.
[0032] (3) Pulverization of resinous medicinal materials After properly crushing frankincense, myrrh, dragon's blood, catechu, and borneol, they are mixed with the above-mentioned powdered herbs, then pulverized and passed through a 100-mesh sieve for later use. This method of mixing and pulverizing with other finely powdered herbs effectively reduces the softening and adhesion of resinous herbs during the pulverization process by utilizing the isolation and dispersion effects of the other powders. The yield results of three batches of pulverized and sieved herbs are as follows:
[0033] The pulverization and sieving yields were all above 93%, indicating that the graded pulverization process is reasonable and feasible.
[0034] Example 2: Selection and Screening of Adhesives This product is a water pill dosage form. Water pills are typically prepared using water, sugar solution, and less than 5% refined honey as a binder. Considering that water pills prepared with sugar solution and refined honey are prone to prolonged dissolution time during storage, water, 10% starch paste, and 10% dextrin were selected as binders for preliminary screening. For each group, 50g of the mixed powder of Chinese medicinal materials was weighed, and a certain amount of binder was added for evaluation.
[0035] Based on the above results, considering that dextrin may affect the determination of the content of traditional Chinese medicine, starch paste was initially selected as the binder.
[0036] To determine the final concentration of the binder, and adhering to the principle of minimizing the amount of excipients, starch pastes with concentrations of 5%, 10%, and 15% were investigated:
[0037] The results showed that production could be carried out using 10% starch paste as a binder, and the amount of auxiliary materials was moderate. The plasticizing method for preparing water pellets has the advantages of high production efficiency, good appearance quality, and rapid dissolution.
[0038] Example 3: Selection of drying conditions Because this product contains volatile components, it is dried at a temperature below 60°C. Three different drying methods—oven drying, fluidized bed drying, and microwave drying—were compared.
[0039] Both fluidized bed drying and microwave drying are characterized by short drying times and high efficiency. Considering all factors, fluidized bed drying and microwave drying have similar efficiencies. Furthermore, microwave drying can sterilize the preparation while drying; therefore, microwave drying was chosen. Microwave drying takes only about 33 minutes, nearly 90% shorter than oven drying (265 minutes).
[0040] IV. Optimal Preparation Process Example 4: Preparation of Guilong Bone-Setting Pills (Optimal Process) Prescription dosage (4 times the amount of raw materials): Safflower 294g, Drynaria fortunei 294g, Vinegar-processed Frankincense 294g, Vinegar-processed Myrrh 294g, Ligusticum chuanxiong 217.6g, Eupolyphaga sinensis 217.6g, Calcined Natural Copper 176g, Angelica sinensis 147.2g, Eucommia ulmoides charcoal 147.2g, Achyranthes bidentata 147.2g, Pheretima aspergillum 147.2g, Panax notoginseng 147.2g, Dragon's Blood 70.4g, Borneol 70.4g, Borax 147.2g, Artemisia capillaris 147.2g, Catechu 147.2g, Evodia rutaecarpa 147.2g, Chaenomeles speciosa 147.2g, Cinnamomum cassia 147.2g, Atractylodes lancea 217.6g, Rheum palmatum 88g, Licorice 147.2g. Starch as needed.
[0041] Preparation method: (1) Graded pulverization: Take three medicinal materials, namely Chuanxiong, Danggui and Cangzhu, mix and pulverize them (without adding a sieve during the pulverization process), and control the material temperature to not exceed 60℃ to obtain the first mixed powder; take the remaining sixteen medicinal materials except vinegar frankincense, vinegar myrrh, blood dragon and borneol, mix and pulverize them to obtain the second mixed powder; combine the first mixed powder, the second mixed powder and vinegar frankincense, vinegar myrrh, blood dragon and borneol (after appropriate crushing), mix and pulverize them, and pass them through a 100-mesh sieve to obtain fine powder of medicinal materials.
[0042] (2) Preparation of starch paste: Take starch and add water to make 10% starch paste.
[0043] (3) Mixing to make soft material: Place the fine powder of medicinal materials obtained in step (1) into a mixer and mix evenly. Add 10% starch paste to make soft material.
[0044] (4) Making pellets: Place the soft material obtained in step (3) into a pellet making machine to make pellets.
[0045] (5) Drying: The pills obtained in step (4) are microwave-dried at a temperature below 60°C to make 1000g, which is Guilong Jiegu Pills.
[0046] V. Three batches of pilot-scale verification Following the optimal process described above, three batches of pilot-scale amplification tests were conducted with four times the amount of the prescription, with batch numbers 01, 02, and 03 respectively.
[0047]
[0048] The results show that the process route is reasonably designed, the quality of intermediates is controllable, the reproducibility is good, and the yield is stable at 91.5%-93.6%, making it suitable for mass production.
[0049] VI. Quality Standards Example 5: Properties This product is a brownish-yellow to brownish-brown water pill; it has a fragrant aroma and a slightly bitter taste.
[0050] Example 6: Thin-layer chromatography identification This product was identified according to the following seven items using thin-layer chromatography in Section IV, General Chapter 0502 of the 2015 edition of the Chinese Pharmacopoeia: (1) Thin-layer chromatographic identification of safflower Take 14g of this product, grind it into a fine powder, add 30ml of methanol, heat under reflux for 30 minutes, filter, and use the filtrate as the test solution. Separately, take 0.5g of safflower reference material and prepare a reference material solution using the same method. Perform thin-layer chromatography, applying 15μl–20μl of each of the above two solutions separately to the same silica gel H thin-layer plate using sodium carboxymethyl cellulose as a binder. Develop the plate using ethyl acetate-formic acid-water-methanol (7:2:3:0.4) as the developing solvent, remove the plate, air-dry it, and examine it under sunlight. In the chromatogram of the test sample, spots of the same color appear at the corresponding positions as in the chromatogram of the reference material.
[0051] (2) Thin-layer chromatographic identification of frankincense and myrrh Take 5g of this product, grind it into a fine powder, add 20ml of ether, soak for 30 minutes, sonicate for 5 minutes, filter, evaporate the filtrate to dryness, dissolve the residue in 1ml of methanol to prepare the test solution. Separately, take 0.5g each of frankincense and myrrh reference materials, and prepare reference material solutions using the same method. Perform thin-layer chromatography, applying 5μl of each of the above three solutions separately to the same silica gel G thin-layer plate. Use petroleum ether (30-60℃)-ethyl acetate (17:1) as the developing solvent, develop, remove, air dry, spray with 5% vanillin-sulfuric acid solution, and heat at 105℃ until the spots are clearly visible. In the chromatogram of the test sample, spots of the same color appear at the corresponding positions as in the chromatogram of the reference materials.
[0052] (3) Thin-layer chromatographic identification of Angelica sinensis and Ligusticum chuanxiong Take 6g of this product, grind it into a fine powder, add 50ml of ether, heat under reflux for 30 minutes, filter, evaporate the filtrate to dryness, dissolve the residue in 2ml of ethyl acetate to prepare the test solution. Separately, take 1g each of Angelica sinensis and Ligusticum chuanxiong reference materials, add 25ml of ether to each, and prepare reference material solutions using the same method. Perform thin-layer chromatography, applying 4μl of each of the above three solutions separately to the same silica gel G thin-layer plate. Develop using n-hexane-ethyl acetate (9:1) as the developing solvent, remove, air dry, and examine under ultraviolet light (365nm). In the chromatogram of the test sample, fluorescent spots of the same color appear at the corresponding positions as in the chromatogram of the reference materials.
[0053] (4) Thin-layer chromatographic identification of Panax notoginseng Take 7g of this product, grind it finely, add 20ml of methanol, sonicate for 30 minutes, filter, evaporate the filtrate to dryness, dissolve the residue in 10ml of water, extract twice with 15ml of water-saturated n-butanol each time, combine the n-butanol extracts, wash twice with 10ml of ammonia solution each time, take the n-butanol extract, evaporate to dryness, dissolve the residue in 1ml of methanol, and use this as the test solution. Separately, take Panax notoginseng saponin R1 reference standard, add methanol to prepare a solution containing 0.5mg per ml, and use this as the reference solution. Perform thin-layer chromatography, taking 5μl of each of the above two solutions, and spot them separately on the same silica gel G thin-layer plate. Use the lower layer solution of chloroform-ethyl acetate-methanol-water (15:40:22:10) stored below 10℃ as the developing solvent, develop, remove, air dry, spray with 10% sulfuric acid ethanol solution, and heat at 105℃ until the spots are clearly visible. In the chromatogram of the test sample, spots of the same color appear at the corresponding positions as in the chromatogram of the reference standard.
[0054] (5) Thin-layer chromatographic identification of catechu Take 3g of this product, grind it into a fine powder, add 30ml of ethanol, sonicate for 15 minutes, filter, evaporate the filtrate to dryness, dissolve the residue in 2ml of methanol, and use this as the test solution. Separately, take 0.1g of catechu reference material and prepare a reference material solution using the same method; take catechin reference standard and prepare a solution containing 0.2mg per ml using methanol, and use this as the reference standard solution. Perform thin-layer chromatography, applying 2-4μl of each of the above solutions separately to the same silica gel H thin-layer plate using sodium carboxymethyl cellulose as a binder. Develop using toluene-ethyl acetate-formic acid (30:25:4) as the developing solvent, remove, air dry, spray with 2% ferric chloride ethanol solution, and heat at 105℃ until the color is clear. In the chromatogram of the test sample, spots of the same color appear at the corresponding positions as in the chromatograms of the reference material and the reference standard.
[0055] (6) Thin-layer chromatographic identification of rhubarb Take 5g of this product, grind it into a fine powder, add 40ml of ethanol, heat under reflux for 30 minutes, filter, evaporate the filtrate to dryness, dissolve the residue in 20ml of water, add 2ml of hydrochloric acid, heat under reflux for 30 minutes, cool, and extract twice with 10ml of ether each time. Combine the ether extracts, evaporate to dryness, and dissolve the residue in 1ml of ethyl acetate to obtain the test solution. Separately, take rhein reference standard, dissolve it in methanol to prepare a solution containing 1mg per ml, and use it as the reference solution. Perform thin-layer chromatography, taking 4μl of each of the above two solutions and spotting them separately on the same silica gel G thin-layer plate. Use n-hexane-ethyl acetate-formic acid (6:2:0.1) as the developing solvent, develop, remove, air dry, and examine under ultraviolet light (365nm). In the chromatogram of the test sample, orange-yellow fluorescent spots appear at the corresponding positions as in the chromatogram of the reference standard; after being exposed to ammonia vapor, the spots turn red.
[0056] (7) Thin-layer chromatographic identification of licorice Take 14g of this product, grind it into a fine powder, add 30ml of methanol, heat under reflux for 1 hour, filter, evaporate the filtrate to dryness, dissolve the residue in 40ml of water, extract three times with 40ml of water-saturated n-butanol each time, combine the n-butanol extracts, wash twice with 30ml of ammonia solution each time, take the n-butanol layer, evaporate to dryness, dissolve the residue in 1ml of methanol, and use this as the test solution. Separately, take 1g of licorice reference material and prepare a reference material solution using the same method; take glycyrrhizin reference standard and prepare a solution containing 1mg per ml with methanol, as the reference solution. Perform thin-layer chromatography, applying 1-2μl of each of the above three solutions separately to the same silica gel G thin-layer plate, developing with ethyl acetate-formic acid-glacial acetic acid-water (15:1:1:2) as the developing solvent, remove, air dry, spray with 10% sulfuric acid ethanol solution, heat at 105℃, and examine under ultraviolet light (365nm). In the chromatogram of the test sample, fluorescent spots of the same color appear at the corresponding positions as in the chromatograms of the reference medicinal material and the reference standard.
[0057] Example 7: Inspection It should comply with all relevant regulations under the category of pills. The test results for the three batches of samples are as follows:
[0058] All test indicators met the requirements.
[0059] VII. Product Properties and Usage Instructions Functions and Indications: Promotes blood circulation, removes blood stasis, relieves pain, and heals tendons and bones. Used to treat swelling and pain in the limbs and joints caused by fractures, dislocations, and soft tissue injuries. Symptoms include swelling and stabbing pain at the affected area, fixed pain that worsens with activity, numbness and contracture, difficulty in flexion and extension of the joints, a purplish-dark tongue with ecchymosis or spots, and a choppy and tight pulse. This syndrome is classified as blood stasis obstructing the collaterals.
[0060] Dosage and administration: Take with warm water after meals. Adults: 4g each time, three times a day. Children: follow doctor's instructions.
[0061] Contraindications: This medicine is contraindicated for pregnant women and those allergic to traditional Chinese medicine. Use with caution in those with impaired liver or kidney function.
[0062] Precautions: Avoid fishy and spicy foods.
[0063] Specifications: 0.6 grams per 10 pills.
[0064] Storage: Seal and store in a dry place.
[0065] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and are not intended to limit it. Although the present invention has been described in detail with reference to preferred embodiments, those skilled in the art should understand that modifications or equivalent substitutions can be made to the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention, and all such modifications or substitutions should be covered within the scope of the claims of the present invention.
Claims
1. A Guilong Bone-Setting Pill, characterized in that, Made from the following Chinese medicinal materials in parts by weight: safflower 65-85 parts, drynaria rhizome 65-85 parts, vinegar-processed frankincense 65-85 parts, vinegar-processed myrrh 65-85 parts, chuanxiong rhizome 45-65 parts, ground beetle 45-65 parts, calcined natural copper 35-55 parts, angelica root 25-45 parts, charred eucommia bark 25-45 parts, achyranthes root 25-45 parts, earthworm 25-45 parts, notoginseng 25-45 parts, dragon's blood 10-25 parts, borneol 10-25 parts, borax 25-45 parts, artemisia capillaris 25-45 parts, catechu 25-45 parts, shiitake mushroom 25-45 parts, papaya 25-45 parts, cinnamon twig 25-45 parts, atractylodes rhizome 45-65 parts, rhubarb 15-30 parts, licorice root 25-45 parts, and pharmaceutically acceptable excipients.
2. The Guilong Bone-Setting Pill according to claim 1, characterized in that: The pharmaceutically acceptable excipient is starch paste.
3. The Guilong Bone-Setting Pill according to claim 1, characterized in that: The specifications of Guilong Jiegu Pills are 0.6 grams per 10 pills.
4. A preparation process for Guilong Jiegu Pills, characterized in that, Includes the following steps: Step 1, Graded Grinding: Take three medicinal materials, Chuanxiong, Danggui, and Cangzhu, mix and grind them to obtain the first mixed powder; take the remaining sixteen medicinal materials, excluding vinegar-processed frankincense, vinegar-processed myrrh, blood dragon, and borneol, mix and grind them to obtain the second mixed powder; combine the first mixed powder, the second mixed powder, and vinegar-processed frankincense, vinegar-processed myrrh, blood dragon, and borneol, mix and grind them, and pass them through a 100-mesh sieve to obtain fine powder of medicinal materials; Step 2, preparation of starch paste: Take starch and add water to make a 10% starch paste; Step 3: Mixing to form a soft material: Place the fine powder of medicinal materials obtained in Step 1 into a mixer and mix evenly. Add the starch paste obtained in Step 2 to form a soft material. Step 4: Pelletizing: Place the soft material obtained in Step 3 into a pelletizing machine to make pellets; Step 5: Drying: The pills obtained in Step 4 are dried in a microwave at a temperature below 60°C to obtain Guilong Jiegu Pills.
5. The preparation process of Guilong Jiegu Pill according to claim 4, characterized in that: In step one, the temperature of the materials during the mixing and pulverizing of the three medicinal materials, namely, Ligusticum chuanxiong, Angelica sinensis, and Atractylodes lancea, is controlled to not exceed 60°C.
6. The preparation process of Guilong Jiegu Pill according to claim 5, characterized in that: In step one, the vinegar-processed frankincense, vinegar-processed myrrh, dragon's blood, and borneol are first subjected to appropriate crushing treatment before being combined and pulverized.
7. The preparation process of Guilong Jiegu Pill according to claim 6, characterized in that: In step five, the microwave drying is carried out at a temperature below 60°C for 30-40 minutes.
8. The preparation process of Guilong Jiegu Pill according to claim 7, characterized in that: In step one, after passing through a 100-mesh sieve, the pulverization and sieving yield is not less than 93%.
9. The Guilong Bone-Setting Pill according to claim 1, characterized in that: Quality identification shall be performed using at least one of the following thin-layer chromatography identification methods: (1) Thin-layer chromatographic identification of safflower: Using safflower reference material as a reference, ethyl acetate-formic acid-water-methanol (7:2:3:0.4) was used as the developing solvent and examined under sunlight; (2) Thin-layer chromatographic identification of frankincense and myrrh: frankincense and myrrh reference materials were used as references, and petroleum ether (30-60℃)-ethyl acetate (17:1) was used as the developing solvent. 5% vanillin sulfuric acid solution was sprayed and heated until the spots were clearly visible. (3) Thin-layer chromatographic identification of Angelica sinensis and Ligusticum chuanxiong: Angelica sinensis and Ligusticum chuanxiong reference materials were used as references, and hexane-ethyl acetate (9:1) was used as the developing solvent. The samples were examined under ultraviolet light (365nm). (4) Thin-layer chromatography identification of Panax notoginseng: Panax notoginseng saponin R1 was used as the reference standard, and the lower layer solution of chloroform-ethyl acetate-methanol-water (15:40:22:10) placed below 10°C was used as the developing solvent. 10% sulfuric acid ethanol solution was sprayed on and heated until the spots were clearly visible. (5) Thin-layer chromatography identification of catechu: using catechu reference material and catechin reference standard as references, using toluene-ethyl acetate-formic acid (30:25:4) as the developing solvent, spraying with 2% ferric chloride ethanol solution, and heating until the spots are clearly visible; (6) Thin-layer chromatographic identification of rhubarb: using rhein as reference standard, n-hexane-ethyl acetate-formic acid (6:2:0.1) as developing solvent, examine under ultraviolet light (365nm), and the spots turn red after being exposed to ammonia vapor; (7) Thin-layer chromatographic identification of licorice: Using licorice reference material and glycyrrhizin reference standard as references, using ethyl acetate-formic acid-glacial acetic acid-water (15:1:1:2) as the developing solvent, spraying with 10% sulfuric acid ethanol solution, heating, and examining under ultraviolet light (365nm).
10. The use of Guilong Jiegu Pill according to any one of claims 1-3 or the Guilong Jiegu Pill prepared by the preparation process according to any one of claims 4-8 in the preparation of a drug for treating fractures, dislocations or soft tissue injuries.
